Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The study by the nonprofit KFF is focused on the jump in overall healthcare prices from 2022 to 2024, with hospitals leading as a result of both delayed care from the pandemic and an increase in prices for services.
The recall has been designated as the most serious, Class I, but the issue can be remedied with a software update. The affected devices are Ivenix Large Volume Pumps manufactured by Fresenius Kabi.
Sycamore Partners took over the struggling retail pharmacy chain roughly six months ago, and the Private Equity Stakeholder Project fears early staffing cuts and store closures could spell trouble for the long-term health of the newly restructured business.
The U.S. Department of Justice and the state attorney general's office allege OhioHealth used its position of market dominance to pressure commercial plans into always keeping its hospitals and clinics in-network, even when competitors offer services for a better rate.
The two said they’ve been negotiating terms for eight months. Sticking points include denied claims and coverage disputes, with both the insurer and health system pointing fingers.
The settlement reached in October 2024 has been finalized. A fund is being set up for the estimated 3 million claimants, as BCBS pledges to reform its BlueCard health plans.
The initial incident happened in April. Since that time, the notorious cybercrime cell Interlock has claimed responsibility. A data dump from the breach was put up for sale on the dark web.
The insurance giant is charging the new board committee with monitoring company policies related to prior authorizations, claims adjudication and AI. The group is scheduled to meet four times a year.
Two lots of IV solution bags from the company were found to contain particulate matter that could cause blockages in blood vessels, killing a patient. To date, no serious adverse events have been reported.
That number includes $285 million in damages. CVS Health’s PBM was found to have committed fraud when it pressured insurers to overbill Medicare Advantage plans for patient care services.
Indiana-based Inotiv confirmed the data breach in a filing with the U.S. Securities and Exchange Commission. Infamous cybercrime cell Qilin has claimed credit for the attack.
Edwards Lifesciences asked the U.S. Federal Trade Commission (FTC) this week to dismiss the complaint against the company's acquisition of JenaValve this week. A healthcare market analysis firm also said the FTC actions will likely impact the timing of an FDA clearance of the Trilogy heart valve.